{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T08:58:42Z","timestamp":1793005122971,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02695-4","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:04:45Z","timestamp":1779667485000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fructose 1-phosphate inhibits mannose phosphate isomerase to suppress hepatocellular carcinogenesis"],"prefix":"10.1038","volume":"11","author":[{"given":"Yongqiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunzhao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaochu","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinran","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhen","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0988-723X","authenticated-orcid":false,"given":"Shan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6456-8231","authenticated-orcid":false,"given":"Hong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus D.","family":"Goncalves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0574-6592","authenticated-orcid":false,"given":"Shanshan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7049-1560","authenticated-orcid":false,"given":"Huiyong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"2695_CR1","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1097\/HEP.0000000000000455","volume":"78","author":"F Yang","year":"2023","unstructured":"Yang, F. et al. Metabolic reprogramming and its clinical implication for liver cancer. Hepatology 78, 1602\u20131624 (2023).","journal-title":"Hepatology"},{"key":"2695_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41586-024-08317-9","volume":"637","author":"L Gu","year":"2025","unstructured":"Gu, L. et al. FBP1 controls liver cancer evolution from senescent MASH hepatocytes. Nature 637, 461\u2013469 (2025).","journal-title":"Nature"},{"key":"2695_CR3","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.cmet.2021.09.010","volume":"33","author":"MA Herman","year":"2021","unstructured":"Herman, M. A. & Birnbaum, M. J. Molecular aspects of fructose metabolism and metabolic disease. Cell Metab. 33, 2329\u20132354 (2021).","journal-title":"Cell Metab."},{"key":"2695_CR4","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1016\/j.cmet.2021.09.004","volume":"33","author":"MA Febbraio","year":"2021","unstructured":"Febbraio, M. A. & Karin, M. \u201cSweet death\u201d: fructose as a metabolic toxin that targets the gut-liver axis. Cell Metab. 33, 2316\u20132328 (2021).","journal-title":"Cell Metab."},{"key":"2695_CR5","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/s41586-025-09098-5","volume":"644","author":"Z Wang","year":"2025","unstructured":"Wang, Z. et al. Early life high fructose impairs microglial phagocytosis and neurodevelopment. Nature 644, 759\u2013768 (2025).","journal-title":"Nature"},{"key":"2695_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41392-025-02359-9","volume":"10","author":"X Ma","year":"2025","unstructured":"Ma, X. et al. High fructose consumption aggravates inflammation by promoting effector T-cell generation by inducing metabolic reprogramming. Signal. Transduct Target Ther. 10, 271 (2025).","journal-title":"Signal. Transduct Target Ther."},{"key":"2695_CR7","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.cmet.2022.05.007","volume":"34","author":"Y Wu","year":"2022","unstructured":"Wu, Y. et al. Glycerate from intestinal fructose metabolism induces islet cell damage and glucose intolerance. Cell Metab. 34, 1042\u20131053 (2022).","journal-title":"Cell Metab."},{"key":"2695_CR8","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.cmet.2024.10.002","volume":"36","author":"H Yan","year":"2024","unstructured":"Yan, H. et al. Hexokinase 2 senses fructose in tumor-associated macrophages to promote colorectal cancer growth. Cell Metab. 36, 2449\u20132467.e2446 (2024).","journal-title":"Cell Metab."},{"key":"2695_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41586-021-03827-2","volume":"597","author":"SR Taylor","year":"2021","unstructured":"Taylor, S. R. et al. Dietary fructose improves intestinal cell survival and nutrient absorption. Nature 597, 263\u2013267 (2021).","journal-title":"Nature"},{"key":"2695_CR10","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1126\/science.aat8515","volume":"363","author":"MD Goncalves","year":"2019","unstructured":"Goncalves, M. D. et al. High-fructose corn syrup enhances intestinal tumor growth in mice. Science 363, 1345\u20131349 (2019).","journal-title":"Science"},{"key":"2695_CR11","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.cmet.2023.09.009","volume":"35","author":"P Zhou","year":"2023","unstructured":"Zhou, P. et al. High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate. Cell Metab. 35, 1961\u20131975.e1966 (2023).","journal-title":"Cell Metab."},{"key":"2695_CR12","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/s42255-020-0261-2","volume":"2","author":"J Todoric","year":"2020","unstructured":"Todoric, J. et al. Fructose stimulated de novo lipogenesis is promoted by inflammation. Nat Metab. 2, 1034\u20131045 (2020).","journal-title":"Nat Metab."},{"key":"2695_CR13","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.cmet.2023.09.011","volume":"35","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Dietary fructose-mediated adipocyte metabolism drives antitumor CD8+ T cell responses. Cell Metab. 35, 2107\u20132118.e2106 (2023).","journal-title":"Cell Metab."},{"key":"2695_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/ijc.25990","volume":"130","author":"N Tasevska","year":"2011","unstructured":"Tasevska, N. et al. Sugars in diet and risk of cancer in the NIH-AARP diet and health study. Int. J. Cancer 130, 159\u2013169 (2011).","journal-title":"Int. J. Cancer"},{"key":"2695_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-60122-6","volume":"14","author":"X Cai","year":"2024","unstructured":"Cai, X. et al. The effect of metabolism-related lifestyle and clinical risk factors on digestive system cancers in East Asian populations: a two-sample Mendelian randomization analysis. Sci. Rep. 14, 9474 (2024).","journal-title":"Sci. Rep."},{"key":"2695_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00394-014-0818-5","volume":"55","author":"M Stepien","year":"2016","unstructured":"Stepien, M. et al. Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort. Eur. J. Nutr. 55, 7\u201320 (2016).","journal-title":"Eur. J. Nutr."},{"key":"2695_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s43018-020-0086-7","volume":"1","author":"M Li","year":"2020","unstructured":"Li, M. et al. Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways. Nat. Cancer 1, 735\u2013747 (2020).","journal-title":"Nat. Cancer"},{"key":"2695_CR18","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1002\/hep.32064","volume":"74","author":"G Liu","year":"2021","unstructured":"Liu, G. et al. Fructose-1,6-bisphosphate aldolase B depletion promotes hepatocellular carcinogenesis through activating insulin receptor signaling and lipogenesis. Hepatology 74, 3037\u20133055 (2021).","journal-title":"Hepatology"},{"key":"2695_CR19","doi-asserted-by":"publisher","first-page":"e3000803","DOI":"10.1371\/journal.pbio.3000803","volume":"18","author":"X He","year":"2020","unstructured":"He, X. et al. Loss of hepatic aldolase B activates Akt and promotes hepatocellular carcinogenesis by destabilizing the Aldob\/Akt\/PP2A protein complex. PLoS Biol. 18, e3000803 (2020).","journal-title":"PLoS Biol."},{"key":"2695_CR20","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41586-024-08258-3","volume":"636","author":"R Fowle-Grider","year":"2024","unstructured":"Fowle-Grider, R. et al. Dietary fructose enhances tumor growth indirectly via interorgan lipid transfer. Nature 636, 737\u2013744 (2024).","journal-title":"Nature"},{"key":"2695_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm7985","volume":"8","author":"SS Tee","year":"2022","unstructured":"Tee, S. S. et al. Ketohexokinase-mediated fructose metabolism is lost in hepatocellular carcinoma and can be leveraged for metabolic imaging. Sci. Adv. 8, eabm7985 (2022).","journal-title":"Sci. Adv."},{"key":"2695_CR22","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"A Ally","year":"2017","unstructured":"Ally, A. et al. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 169, 1327\u20131341.e1323 (2017).","journal-title":"Cell"},{"key":"2695_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1136\/jmg.35.5.353","volume":"35","author":"M Ali","year":"1998","unstructured":"Ali, M., Rellos, P. & Cox, T. M. Hereditary fructose intolerance. J. Med. Genet. 35, 353\u2013365 (1998).","journal-title":"J. Med. Genet."},{"key":"2695_CR24","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1096\/fasebj.8.1.8299892","volume":"8","author":"TM Cox","year":"1994","unstructured":"Cox, T. M. Aldolase B and fructose intolerance. FASEB J. 8, 62\u201371 (1994).","journal-title":"FASEB J."},{"key":"2695_CR25","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1172\/JCI94427","volume":"128","author":"MA Lanaspa","year":"2018","unstructured":"Lanaspa, M. A. et al. Ketohexokinase C blockade ameliorates fructose-induced metabolic dysfunction in fructose-sensitive mice. J. Clin. Investig. 128, 2226\u20132238 (2018).","journal-title":"J. Clin. Investig."},{"key":"2695_CR26","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40170-021-00246-9","volume":"9","author":"RJ Liang","year":"2021","unstructured":"Liang, R. J. et al. GLUT5 (SLC2A5) enables fructose-mediated proliferation independent of ketohexokinase. Cancer Metab. 9, 12 (2021).","journal-title":"Cancer Metab."},{"key":"2695_CR27","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-018-0597-x","volume":"562","author":"M Song","year":"2018","unstructured":"Song, M. et al. IRE1alpha-XBP1 controls T-cell function in ovarian cancer by regulating mitochondrial activity. Nature 562, 423\u2013428 (2018).","journal-title":"Nature"},{"key":"2695_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3389\/fonc.2020.00496","volume":"10","author":"T Zhao","year":"2020","unstructured":"Zhao, T. et al. Heterogeneities of site-specific N-glycosylation in HCC tumors with low and high AFP concentrations. Front. Oncol. 10, 496 (2020).","journal-title":"Front. Oncol."},{"key":"2695_CR29","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.cell.2017.12.006","volume":"172","author":"I Piazza","year":"2018","unstructured":"Piazza, I. et al. A map of protein-metabolite interactions reveals principles of chemical communication. Cell 172, 358\u2013372.e323 (2018).","journal-title":"Cell"},{"key":"2695_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1208\/s12248-012-9449-z","volume":"15","author":"L Wang","year":"2013","unstructured":"Wang, L. et al. TargetHunter: an in silico target identification tool for predicting therapeutic potential of small organic molecules based on chemogenomic database. AAPS J. 15, 395\u2013406 (2013).","journal-title":"AAPS J."},{"key":"2695_CR31","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1021\/bi4000782","volume":"52","author":"A Pautsch","year":"2013","unstructured":"Pautsch, A. et al. Crystal structure of glucokinase regulatory protein. Biochemistry 52, 3523\u20133531 (2013).","journal-title":"Biochemistry"},{"key":"2695_CR32","doi-asserted-by":"publisher","first-page":"39431","DOI":"10.1074\/jbc.M111.285502","volume":"286","author":"V Sharma","year":"2011","unstructured":"Sharma, V. et al. Phosphomannose isomerase inhibitors improve N-glycosylation in selected phosphomannomutase-deficient fibroblasts. J. Biol. Chem. 286, 39431\u201339438 (2011).","journal-title":"J. Biol. Chem."},{"key":"2695_CR33","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1111\/j.1651-2227.2002.tb00101.x","volume":"91","author":"HK Harms","year":"2002","unstructured":"Harms, H. K. et al. Oral mannose therapy persistently corrects the severe clinical symptoms and biochemical abnormalities of phosphomannose isomerase deficiency. Acta Paediatr. 91, 1065\u20131072 (2002).","journal-title":"Acta Paediatr."},{"key":"2695_CR34","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/adc.85.4.339","volume":"85","author":"CJ Hendriksz","year":"2001","unstructured":"Hendriksz, C. J. et al. Successful treatment of carbohydrate deficient glycoprotein syndrome type 1b with oral mannose. Arch Dis. Child 85, 339\u2013340 (2001).","journal-title":"Arch Dis. Child"},{"key":"2695_CR35","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10545-009-1219-4","volume":"32","author":"E Quintana","year":"2009","unstructured":"Quintana, E. et al. Secondary disorders of glycosylation in inborn errors of fructose metabolism. J. Inherit. Metab. Dis. 32, 273\u2013278 (2009).","journal-title":"J. Inherit. Metab. Dis."},{"key":"2695_CR36","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1203\/00006450-199611000-00017","volume":"40","author":"E van Schaftingen","year":"1996","unstructured":"van Schaftingen, E., Jaeken, J., Pirard, M., Adamowicz, M. & Pronicka, E. Inhibition of phosphomannose isomerase by fructose 1-phosphate: an explanation for defective N-glycosylation in hereditary fructose intolerance. Pediatr Res. 40, 764\u2013766 (1996).","journal-title":"Pediatr Res."},{"key":"2695_CR37","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.3390\/molecules26144230","volume":"26","author":"C Santi","year":"2021","unstructured":"Santi, C., Scimmi, C. & Sancineto, L. Ebselen and analogs: pharmacological properties and synthetic strategies for their preparation. Molecules 26, 4230 (2021).","journal-title":"Molecules"},{"key":"2695_CR38","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","volume":"582","author":"Z Jin","year":"2020","unstructured":"Jin, Z. et al. Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors. Nature 582, 289\u2013293 (2020).","journal-title":"Nature"},{"key":"2695_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37652-0","volume":"14","author":"K Woodley","year":"2023","unstructured":"Woodley, K. et al. Mannose metabolism inhibition sensitizes acute myeloid leukemia cells to therapy by driving ferroptotic cell death. Nat. Commun. 14, 2132 (2023).","journal-title":"Nat. Commun."},{"key":"2695_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20164-6","volume":"11","author":"S Torretta","year":"2020","unstructured":"Torretta, S. et al. D-mannose suppresses macrophage IL-1\u03b2 production. Nat Commun 11, 6343 (2020).","journal-title":"Nat Commun"},{"key":"2695_CR41","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41586-018-0729-3","volume":"563","author":"PS Gonzalez","year":"2018","unstructured":"Gonzalez, P. S. et al. Mannose impairs tumor growth and enhances chemotherapy. Nature 563, 719\u2013723 (2018).","journal-title":"Nature"},{"key":"2695_CR42","doi-asserted-by":"publisher","first-page":"13546","DOI":"10.1021\/acs.jmedchem.0c00944","volume":"63","author":"K Futatsugi","year":"2020","unstructured":"Futatsugi, K. et al. Discovery of PF-06835919: a potent inhibitor of ketohexokinase (KHK) for the treatment of metabolic disorders driven by the overconsumption of fructose. J. Med. Chem. 63, 13546\u201313560 (2020).","journal-title":"J. Med. Chem."},{"key":"2695_CR43","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2018.11.011","volume":"176","author":"SH Moon","year":"2019","unstructured":"Moon, S. H. et al. p53 represses the mevalonate pathway to mediate tumor suppression. Cell 176, 564\u2013580.e519 (2019).","journal-title":"Cell"},{"key":"2695_CR44","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/HEP.0000000000000704","volume":"81","author":"C Yin","year":"2025","unstructured":"Yin, C. et al. ALDOB\/KAT2A interactions epigenetically modulate TGF-\u03b2 expression and T-cell functions in hepatocellular carcinogenesis. Hepatology 81, 77\u201393 (2025).","journal-title":"Hepatology"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02695-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02695-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02695-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:04:46Z","timestamp":1779667486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02695-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2695"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02695-4","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"20 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.H.Y., S.S.Z., and Y.Q.W. are inventors on a patent application filed to use ebselen as a new therapeutic agent for HCC. The other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}